Gsk'547

Gsk'547

AOB17116

CAS 2226735-55-1

More details

1000 Items

$0.00

Overview

Novel mono-selective RIP1 kinase inhibitor, being tumor-protective via macrophage-mediated Th1/Th17 and CTL activation, synergizing with checkpoint- and co-stimulatory receptor-based immunotherapies